When Dr. Christopher McIntyre, a nephrologist from the United Kingdom and currently practicing in London, Ontario, Canada, found that unconventional, non-clinical parameters appeared to foreshadow deteriorating health in pediatric dialysis patients, he conceived of an approach to assess patients on a routine basis. This approach would evolve to not only enhance patient lives but also assess novel approaches to treatments and their clinical outcome. As interest in these approaches grew, Dr. McIntyre established a company in 2024 to enable these approaches to be utilized around the world.

Today, we are a pioneering data sciences company focused within the medical technology industry and, alongside our customers, we are inspired to impact the lives of millions of individuals fighting chronic disease each year. Our array of innovative solutions and services for chronic disease management help improve patient lives and enhance healthcare outcomes. As our portfolio grows, our culture reflects Dr. McIntyre’s philosophy and we are well-positioned to continue making healthcare better for generations to come.